PRESS RELEASE published on 01/27/2025 at 18:55, 1 year 3 months ago EQS-Adhoc: Eckert & Ziegler Announces Preliminary Figures for 2024: Significant Increase in Sales and Adjusted EBIT Eckert & Ziegler SE announces preliminary figures for 2024 with a significant increase in sales and adjusted EBIT. Sales up 20% to EUR 295 million, EBIT raised to EUR 66 million Preliminary Results Adjusted EBIT Sales Increase Eckert & Ziegler SE 2024 Financial Year
BRIEF published on 01/14/2025 at 17:08, 1 year 4 months ago Eckert & Ziegler Partners with Chinese Joint Venture for Actinium-225 Production Clinical Trials Radiopharmaceuticals Licence Agreement Actinium-225 Supply Expansion
PRESS RELEASE published on 01/14/2025 at 17:03, 1 year 4 months ago EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE signs licence agreement with Chinese joint venture for Ac-225 cyclotron technology, aiming to increase supply of Ac-225 for radiopharmaceutical industry Radiopharmaceutical Industry Eckert & Ziegler SE Licence Agreement Ac-225 Chinese Joint Venture
BRIEF published on 01/13/2025 at 10:05, 1 year 4 months ago Eckert & Ziegler and GlyTherix Expand Collaboration with Actinium-225 Supply Agreement Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Actinium-225 GlyTherix
PRESS RELEASE published on 01/13/2025 at 10:00, 1 year 4 months ago Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement Eckert & Ziegler and GlyTherix extend collaboration with Actinium-225 supply agreement, enhancing cancer therapy access globally Eckert & Ziegler Collaboration Actinium-225 GlyTherix Radiotherapy
BRIEF published on 12/13/2024 at 09:05, 1 year 5 months ago Eckert & Ziegler Seeks Approval for GalliaPharm® in Japan Diagnostic Imaging Regulatory Approval Nuclear Medicine Japanese Market GalliaPharm®
PRESS RELEASE published on 12/13/2024 at 09:00, 1 year 5 months ago Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW Eckert & Ziegler submits GalliaPharm for approval in Japan, expanding access to advanced diagnostic tools like 68Ga-PSMA-11, enhancing precision in oncology imaging Oncology Eckert & Ziegler Diagnostic Imaging Japan Approval GalliaPharm
BRIEF published on 12/05/2024 at 09:35, 1 year 5 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement Cancer Treatment Precision Medicine Radiopharmaceuticals Supply Agreement Isotopes
PRESS RELEASE published on 12/05/2024 at 09:30, 1 year 5 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments Eckert & Ziegler and Ariceum Therapeutics sign global supply agreement for developing next-generation radiotherapeutics. Collaboration to accelerate targeted cancer treatments Eckert & Ziegler Ariceum Therapeutics Global Supply Agreement Radiotherapeutics Precision Cancer Treatments
BRIEF published on 12/03/2024 at 14:34, 1 year 5 months ago Eckert & Ziegler Announces Executive and Supervisory Board Changes Executive Board Supervisory Board Eckert & Ziegler Dr. Gunnar Mann Jutta Ludwig
Published on 05/27/2026 at 15:25, 3 hours 21 minutes ago LaFleur Announces Upsize of Bought Deal Equity Offerings for Gross Proceeds of C$10 Million
Published on 05/27/2026 at 15:22, 3 hours 24 minutes ago AmeriTrust Announces First Quarter 2026 Financial Results
Published on 05/27/2026 at 15:15, 3 hours 31 minutes ago Storm Exploration Begins Field Program on VMS Target at Gold Standard
Published on 05/27/2026 at 15:00, 3 hours 46 minutes ago Jaguar Health Compliant with Nasdaq Bid Price Rule
Published on 05/27/2026 at 14:49, 3 hours 57 minutes ago Sekur Private Data Signs Defense Distribution Agreement with Elyon International, Marking Strategic Shift to Defense, Government and Enterprise Communications
Published on 05/27/2026 at 18:30, 16 minutes ago Avolta secures 12-year contract at Norfolk International Airport, introducing hybrid formats
Published on 05/27/2026 at 18:13, 32 minutes ago Energiekontor AG: Annual General Meeting approves all agenda items by a large majority
Published on 05/27/2026 at 17:40, 1 hour 6 minutes ago VALBIOTIS SA: Monacolins from Red Yeast Rice: On May 13, EU Member States voted in favor of the draft regulation aimed at banning monacolins from red yeast rice
Published on 05/27/2026 at 17:30, 1 hour 16 minutes ago Shelly Group SE Convenes Annual General Meeting
Published on 05/27/2026 at 17:45, 1 hour 1 minute ago Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 1 hour 1 minute ago Description of Share buyback program - May 2026
Published on 05/27/2026 at 17:45, 1 hour 1 minute ago Report on share repurchases from 20 to 26 May 2026
Published on 05/27/2026 at 17:45, 1 hour 1 minute ago Report ordinary & special general meeting of May 27, 2026
Published on 05/27/2026 at 11:51, 6 hours 54 minutes ago Statement of transactions in own shares from May 18, 2026 to May 22, 2026